| [relationship between the distribution of hepatitis b virus genotypes and clinical types of the disease in han nationality hepatitis b patients in xinjiang]. | | 2005 | 16313735 |
| [a study on the prevalence rates of human immunodeficiency virus, hepatitis b virus and hepatitis c virus infections in intravenous drug users]. | to study hiv, hbv and hcv infections in intravenous drug users. | 2006 | 17299963 |
| [distribution and characteristics of hepatitis b virus genotypes in uighur patients with chronic hepatitis b in xinjiang province of china]. | to study genotype distribution and the characteristics of hepatitis b virus (hbv) in uighur patients with chronic hepatitis b (chb) in xinjiang, china. | 2007 | 17456307 |
| epidemiology of hepatitis c virus infection among injection drug users in china: systematic review and meta-analysis. | injection drug use (idu) is the predominant mode of hepatitis c virus (hcv) transmission in china. this paper aims to provide a comprehensive and reliable tabulation of available data on the epidemiological characteristics and risk factors for hcv infection in injection drug users (idus) in china to help inform prevention programmes and guide future research. | 2008 | 18486955 |
| [preliminary study on genotype of hepatitis b virus detected from xinjiang uygur autonomous region in china]. | to determine the main genotype of hepatitis b virus (hbv) in xinjiang. | 2009 | 20387482 |
| multiple viral coinfections among hiv/aids patients in china. | a cross-sectional survey was conducted to determine seroprevalence and correlates of coinfections of hepatitis b virus (hbv), hepatitis c virus (hcv), epstein-bar virus (ebv), herpes simplex virus including type 1 (hsv-1) and type 2 (hsv-2) among human immunodeficiency virus (hiv)/acquired immunodeficiency syndrome (aids) patients in china. a total of 1,110 hiv/aids patients from shanxi (central area, n = 287), zhejiang (eastern area, n = 163), yunnan (southwestern area, n = 300) and xinjiang (n ... | 2011 | 21422594 |
| modeling and analyzing the transmission dynamics of hbv epidemic in xinjiang, china. | hepatitis b is an infectious disease caused by the hepatitis b virus (hbv) which affects livers. in this paper, we formulate a hepatitis b model to study the transmission dynamics of hepatitis b in xinjiang, china. the epidemic model involves an exponential birth rate and vertical transmission. for a better understanding of hbv transmission dynamics, we analyze the dynamic behavior of the model. the modified reproductive number σ is obtained. when σ < 1, the disease-free equilibrium is locally a ... | 2015 | 26422614 |
| [clinical epidemiological analysis of 3602 cases of primary liver cancer in xinjiang]. | to investigate the clinical epidemiological characteristics and the major causes of primary liver cancer (plc) in xinjiang region. | 2012 | 22883460 |
| hbv/d1: a major hbv subgenotype circulating in uyghur patients with chronic hbv infection in xinjiang, china. | each hepatitis b virus (hbv) genotype and subgenotype is associated with a particular geographic distribution, ethnicity, and anthropological history. the present study investigated the genomic characteristics of hbv from uyghur patients with chronic hbv infection in xinjiang, china. among the 53 uyghur patients enrolled, hbv/d was found to be the dominant strain, with 64.2 % (34/53), 60.4 % (32/53) with hbv/d1 and 3.8 % (2/53) with hbv/d3. in addition to these findings, 3.8 % hbv/b (2/53), 5.7 ... | 2012 | 22610589 |
| serum microrna-30c levels are correlated with disease progression in xinjiang uygur patients with chronic hepatitis b. | we aimed to investigate the potential role and mechanism of microrna-30c (mir-30c) in the pathological development of chronic hepatitis b (chb). the serum levels of mir-30c in hepatitis b virus (hbv) carrier xinjiang uygur patients with inactive, low-replicative, high-replicative and hbe antigen-positive chb were investigated. hepg2 cells were co-transfected with phbv1.3 and mir-30c mimic or inhibitor or scramble rna. the effects of mir-30c dysregulation on hbv replication and gene expression, c ... | 2017 | 28492809 |